Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · IEX Real-Time Price · USD
19.92
+0.98 (5.17%)
At close: Jul 19, 2024, 4:00 PM
19.99
+0.07 (0.35%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Castle Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2017
Revenue
250.73219.79137.0494.0962.6551.87
Upgrade
Revenue Growth (YoY)
64.71%60.38%45.65%50.18%20.79%127.62%
Upgrade
Cost of Revenue
48.6944.9832.0115.829.697.31
Upgrade
Gross Profit
202.03174.81105.0378.2652.9644.56
Upgrade
Selling, General & Admin
181.89180.1514386.7448.1329.84
Upgrade
Research & Development
53.0353.6244.929.6513.267.39
Upgrade
Other Operating Expenses
9.049.018.271.96-1.880
Upgrade
Operating Expenses
243.96242.78196.17118.3459.5137.23
Upgrade
Operating Income
-41.93-67.98-91.14-40.08-6.547.33
Upgrade
Interest Expense / Income
0.020.010.0202.634.57
Upgrade
Other Expense / Income
-11.28-10.62-22.26-0.071.02-2.59
Upgrade
Pretax Income
-30.66-57.37-68.9-40.01-10.25.35
Upgrade
Income Tax
0.130.1-1.77-8.720.080.07
Upgrade
Net Income
-30.8-57.47-67.14-31.29-10.285.28
Upgrade
Preferred Dividends
000002.29
Upgrade
Net Income Common
-30.8-57.47-67.14-31.29-10.282.99
Upgrade
Shares Outstanding (Basic)
27272625199
Upgrade
Shares Outstanding (Diluted)
27272625199
Upgrade
Shares Change
3.30%2.87%3.65%32.80%118.63%354.25%
Upgrade
EPS (Basic)
-1.14-2.14-2.58-1.24-0.540.35
Upgrade
EPS (Diluted)
-1.14-2.14-2.58-1.24-0.54-0.21
Upgrade
Free Cash Flow
-6.44-19.23-47.09-22.465.126.08
Upgrade
Free Cash Flow Per Share
-0.23-0.72-1.81-0.890.270.71
Upgrade
Gross Margin
80.58%79.53%76.64%83.18%84.54%85.91%
Upgrade
Operating Margin
-16.72%-30.93%-66.51%-42.60%-10.44%14.13%
Upgrade
Profit Margin
-12.28%-26.15%-48.99%-33.26%-16.42%5.77%
Upgrade
Free Cash Flow Margin
-2.57%-8.75%-34.36%-23.87%8.17%11.72%
Upgrade
Effective Tax Rate
-----1.35%
Upgrade
EBITDA
-17.87-45.02-58.34-36.6-7.0910.28
Upgrade
EBITDA Margin
-7.13%-20.49%-42.57%-38.91%-11.32%19.82%
Upgrade
Depreciation & Amortization
12.7812.3310.543.410.470.36
Upgrade
EBIT
-30.64-57.35-68.89-40.01-7.579.92
Upgrade
EBIT Margin
-12.22%-26.10%-50.27%-42.53%-12.08%19.13%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).